Among Asian patients, a high proportion of head and neck malignant melanomas (HNMs) are of the nodular subtype and are associated with poor outcomes and low survival, researchers reported in Melanoma Research.
2023
Study uncovers how B cells react to skin cancer
A new study that sheds light on how B cells react to skin cancer cells could pave the way for innovative therapy design.
Cancer Vaccine mRNA-4157 Improves Recurrence-Free Survival for Patients With High-Risk Melanoma
Adjuvant treatment with mRNA-4157 plus pembrolizumab led to a 65% reduction in the risk of distant metastasis or death compared with pembrolizumab alone, among patients with resected melanoma at high risk of recurrence, according to findings from the phase 2 KEYNOTE-942 trial (NCT03897881) that were presented at the 2023 ASCO Annual Meeting.
Research Reveals How B Cells Respond to Skin Cancer
A new study that sheds light on how B cells react to skin cancer cells could pave the way for innovative therapy design.